226 related articles for article (PubMed ID: 34586537)
1. Treatment Approach to Adenocarcinoma of the Ampulla of Vater.
Patel M; Uboha NV
Curr Treat Options Oncol; 2021 Sep; 22(11):103. PubMed ID: 34586537
[TBL] [Abstract][Full Text] [Related]
2. Role of Adjuvant Multimodality Therapy After Curative-Intent Resection of Ampullary Carcinoma.
Ecker BL; Vollmer CM; Behrman SW; Allegrini V; Aversa J; Ball CG; Barrows CE; Berger AC; Cagigas MN; Christein JD; Dixon E; Fisher WE; Freedman-Weiss M; Guzman-Pruneda F; Hollis RH; House MG; Kent TS; Kowalsky SJ; Malleo G; Salem RR; Salvia R; Schmidt CR; Seykora TF; Zheng R; Zureikat AH; Dickson PV
JAMA Surg; 2019 Aug; 154(8):706-714. PubMed ID: 31141112
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of pathologic subtype in curatively resected ampulla of vater cancer.
Kim WS; Choi DW; Choi SH; Heo JS; You DD; Lee HG
J Surg Oncol; 2012 Mar; 105(3):266-72. PubMed ID: 21882202
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant therapy for true ampullary cancer: a systematic review.
Bonet M; Rodrigo A; Vázquez S; Carrizo V; Vilardell F; Mira M
Clin Transl Oncol; 2020 Aug; 22(8):1407-1413. PubMed ID: 31927720
[TBL] [Abstract][Full Text] [Related]
5. Ampullary Adenocarcinoma, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology.
Chiorean EG; Chiaro MD; Tempero MA; Malafa MP; Benson AB; Cardin DB; Christensen JA; Chung V; Czito B; Dillhoff M; Donahue TR; Dotan E; Fountzilas C; Glazer ES; Hardacre J; Hawkins WG; Klute K; Ko AH; Kunstman JW; LoConte N; Lowy AM; Masood A; Moravek C; Nakakura EK; Narang AK; Nardo L; Obando J; Polanco PM; Reddy S; Reyngold M; Scaife C; Shen J; Truty MJ; Vollmer C; Wolff RA; Wolpin BM; Rn BM; Lubin S; Darlow SD
J Natl Compr Canc Netw; 2023 Jul; 21(7):753-782. PubMed ID: 37433437
[TBL] [Abstract][Full Text] [Related]
6. Low incidence of KRAS, BRAF, and PIK3CA mutations in adenocarcinomas of the ampulla of Vater and their prognostic value.
Kwon MJ; Kim JW; Jung JP; Cho JW; Nam ES; Cho SJ; Kim JS; Park HR; Min SK; Seo J; Min KW; Kim DH; Jeon JY
Hum Pathol; 2016 Apr; 50():90-100. PubMed ID: 26997442
[TBL] [Abstract][Full Text] [Related]
7. Factors predicting survival and pathological subtype in patients with ampullary adenocarcinoma.
Okano K; Oshima M; Yachida S; Kushida Y; Kato K; Kamada H; Wato M; Nishihira T; Fukuda Y; Maeba T; Inoue H; Masaki T; Suzuki Y
J Surg Oncol; 2014 Aug; 110(2):156-62. PubMed ID: 24619853
[TBL] [Abstract][Full Text] [Related]
8. Updated therapeutic outcome for patients with periampullary and pancreatic cancer related to recent translational research.
Buanes TA
World J Gastroenterol; 2016 Dec; 22(48):10502-10511. PubMed ID: 28082802
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant treatment for ampullary cancer. Highlights from the "2011 ASCO Annual Meeting". Chicago, IL, USA; June 3-7, 2011.
Kim R; Chabot J; Saif MW
JOP; 2011 Jul; 12(4):362-3. PubMed ID: 21737897
[TBL] [Abstract][Full Text] [Related]
10. [Multimodal treatment of periampullary carcinoma].
Reißig TM; Siveke JT
Chirurg; 2021 Sep; 92(9):803-808. PubMed ID: 34228145
[TBL] [Abstract][Full Text] [Related]
11. Twenty-six cases of advanced ampullary adenocarcinoma treated with systemic chemotherapy.
Shoji H; Morizane C; Hiraoka N; Kondo S; Ueno H; Ohno I; Shimizu S; Mitsunaga S; Ikeda M; Okusaka T
Jpn J Clin Oncol; 2014 Apr; 44(4):324-30. PubMed ID: 24482413
[TBL] [Abstract][Full Text] [Related]
12. Current strategies in the therapeutic approach for adenocarcinoma of the ampulla of Vater.
Gaspar B; Beuran M; Paun S; Ganescu R; Hostiuc S; Negoi I
J Med Life; 2013 Sep; 6(3):260-5. PubMed ID: 24146684
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant chemoradiation versus surgery alone for adenocarcinoma of the ampulla of Vater.
Zhou J; Hsu CC; Winter JM; Pawlik TM; Laheru D; Hughes MA; Donehower R; Wolfgang C; Akbar U; Schulick R; Cameron J; Herman JM
Radiother Oncol; 2009 Aug; 92(2):244-8. PubMed ID: 19541379
[TBL] [Abstract][Full Text] [Related]
14. Carcinoma of the ampulla of Vater: patterns of failure following resection and benefit of chemoradiotherapy.
Palta M; Patel P; Broadwater G; Willett C; Pepek J; Tyler D; Zafar SY; Uronis H; Hurwitz H; White R; Czito B
Ann Surg Oncol; 2012 May; 19(5):1535-40. PubMed ID: 22045467
[TBL] [Abstract][Full Text] [Related]
15. Clinico-pathological correlates and survival outcomes in 214 resected ampullary adenocarcinomas - are outcomes different in intestinal and pancreatobiliary subtypes with adjuvant gemcitabine?
Ramaswamy A; Bhandare M; Bal M; Shrirangwar S; Kataria P; Majumdar S; Swami R; Rohila J; Chaudhari V; Mandavkar S; Chavan N; Shrikhande SV; Ostwal V
HPB (Oxford); 2020 Mar; 22(3):376-382. PubMed ID: 31405778
[TBL] [Abstract][Full Text] [Related]
16. Influence of Preoperative Therapy on Short- and Long-Term Outcomes of Patients with Adenocarcinoma of the Ampulla of Vater.
Cloyd JM; Wang H; Overman M; Zhao J; Denbo J; Prakash L; Kim MP; Shroff R; Javle M; Varadhachary GR; Fogelman D; Wolff RA; Koay EJ; Das P; Maitra A; Aloia TA; Vauthey JN; Fleming JB; Lee JE; Katz MHG
Ann Surg Oncol; 2017 Jul; 24(7):2031-2039. PubMed ID: 28124275
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of adjuvant chemoradiation therapy for ampullary adenocarcinoma: the Johns Hopkins Hospital-Mayo Clinic collaborative study.
Narang AK; Miller RC; Hsu CC; Bhatia S; Pawlik TM; Laheru D; Hruban RH; Zhou J; Winter JM; Haddock MG; Donohue JH; Schulick RD; Wolfgang CL; Cameron JL; Herman JM
Radiat Oncol; 2011 Sep; 6():126. PubMed ID: 21951377
[TBL] [Abstract][Full Text] [Related]
18. Histopathologic features and microsatellite instability of cancers of the papilla of vater and their precursor lesions.
Ruemmele P; Dietmaier W; Terracciano L; Tornillo L; Bataille F; Kaiser A; Wuensch PH; Heinmoeller E; Homayounfar K; Luettges J; Kloeppel G; Sessa F; Edmonston TB; Schneider-Stock R; Klinkhammer-Schalke M; Pauer A; Schick S; Hofstaedter F; Baumhoer D; Hartmann A
Am J Surg Pathol; 2009 May; 33(5):691-704. PubMed ID: 19252434
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant intra-arterial chemotherapy and radiotherapy versus surgery alone in resectable pancreatic and periampullary cancer: a prospective randomized controlled trial.
Morak MJ; van der Gaast A; Incrocci L; van Dekken H; Hermans JJ; Jeekel J; Hop WC; Kazemier G; van Eijck CH
Ann Surg; 2008 Dec; 248(6):1031-41. PubMed ID: 19092348
[TBL] [Abstract][Full Text] [Related]
20. Performance and prognostic utility of the 92-gene assay in the molecular subclassification of ampullary adenocarcinoma.
Overman MJ; Soifer HS; Schueneman AJ; Ensor J; Adsay V; Saka B; Neishaboori N; Wolff RA; Wang H; Schnabel CA; Varadhachary G
BMC Cancer; 2016 Aug; 16(1):668. PubMed ID: 27549176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
